Similar tumor suppressing activity has been well documented for another HSP40 members—DNAJB6, overexpression of which reduces malignancy and is responsible for partial reversal of the mesenchymal phenotypes in breast cancer, in vitro and in vivo [68,69] (Figure 3). The gene discussed is DNAJB1; the disease is neoplasm.